Published in Am J Gastroenterol on September 01, 2007
Natural history of pancreatitis-induced splenic vein thrombosis: a systematic review and meta-analysis of its incidence and rate of gastrointestinal bleeding. HPB (Oxford) (2011) 1.54
Treatment of portal hypertension. World J Gastroenterol (2012) 1.39
External validation of the platelet count/spleen diameter ratio for the diagnosis of esophageal varices in hepatitis C virus-related cirrhosis. Dig Dis Sci (2008) 1.02
Cirrhosis and its complications: evidence based treatment. World J Gastroenterol (2014) 0.93
Update on gastric varices. World J Gastrointest Endosc (2014) 0.89
Varices and Variceal Hemorrhage in Cirrhosis: A New View of an Old Problem. Clin Gastroenterol Hepatol (2015) 0.86
Pharmacotherapy for alcoholic patients with alcoholic liver disease. Am J Health Syst Pharm (2014) 0.86
Platelet count/spleen diameter ratio to predict esophageal varices in Mexican patients with hepatic cirrhosis. World J Gastroenterol (2014) 0.85
Endoscopic band ligation versus pharmacological therapy for variceal bleeding in cirrhosis: a meta-analysis. Can J Gastroenterol (2011) 0.84
Liver stiffness measurement by fibroscan predicts the presence and size of esophageal varices in egyptian patients with HCV related liver cirrhosis. J Clin Diagn Res (2013) 0.84
Benefit of combination β-blocker and endoscopic treatment to prevent variceal rebleeding: a meta-analysis. World J Gastroenterol (2010) 0.83
New model for end stage liver disease improves prognostic capability after transjugular intrahepatic portosystemic shunt. Clin Gastroenterol Hepatol (2009) 0.83
The safety and efficacy of laparoscopic and open hepatectomy in hepatocellular carcinoma patients with liver cirrhosis: a systematic review. Int J Clin Exp Med (2015) 0.82
Improved survival with the patients with variceal bleed. Int J Hepatol (2011) 0.81
Late Presentation of Fulminant Necrotizing Enterocolitis in a Child with Hyperinsulinism on Octreotide Therapy. Horm Res Paediatr (2016) 0.81
Venous thromboembolism in cirrhosis. Clin Appl Thromb Hemost (2012) 0.80
Successful endoscopic sclerotherapy for bleeding gastric varices with combined cyanoacrylate and aethoxysklerol. World J Gastroenterol (2008) 0.80
Role of prophylactic antibiotics in cirrhotic patients with variceal bleeding. World J Gastroenterol (2014) 0.80
Doppler assessment of hepatic venous waves for predicting large varices in cirrhotic patients. Saudi J Gastroenterol (2011) 0.80
Endoscopic band ligation versus endoscopic submucosal dissection and laparoscopic resection for small gastric stromal tumors. Surg Endosc (2015) 0.79
Portal hypertension as immune mediate disease. Hepat Mon (2014) 0.78
Adherence to guidelines: a national audit of the management of acute upper gastrointestinal bleeding. The REASON registry. Can J Gastroenterol Hepatol (2014) 0.78
Idiopathic Noncirrhotic Portal Hypertension: An Appraisal. J Pathol Transl Med (2015) 0.78
Esophageal varices on computed tomography and subsequent variceal hemorrhage. Abdom Imaging (2014) 0.77
Low risk of bacteremia after endoscopic variceal therapy for esophageal varices: a systematic review and meta-analysis. Endosc Int Open (2015) 0.77
Quality improvement in gastroenterology clinical practice. Clin Gastroenterol Hepatol (2012) 0.77
Role of interventional radiology in the emergent management of acute upper gastrointestinal bleeding. Semin Intervent Radiol (2012) 0.76
Complications of end-stage liver disease. Can Fam Physician (2016) 0.75
Management options in decompensated cirrhosis. Hepat Med (2015) 0.75
Correlation of platelets count with endoscopic findings in a cohort of Egyptian patients with liver cirrhosis. Medicine (Baltimore) (2016) 0.75
Use of Wireless Capsule Endoscopy for the Diagnosis and Grading of Esophageal Varices in Patients With Portal Hypertension: A Systematic Review and Meta-Analysis. J Clin Gastroenterol (2016) 0.75
Portal vein Doppler: a tool for non-invasive prediction of esophageal varices in cirrhosis. J Clin Diagn Res (2014) 0.75
Study on assessment of renal function in chronic liver disease. J Clin Diagn Res (2015) 0.75
Management of Variceal Hemorrhage. Gastroenterology Res (2009) 0.75
Transoesophageal echocardiography during liver transplantation. World J Hepatol (2015) 0.75
Complications related to intraoperative transesophageal echocardiography in liver transplantation. Springerplus (2015) 0.75
Effect of intravariceal sclerotherapy combined with esophageal mucosal sclerotherapy using small-volume sclerosant for cirrhotic patients with high variceal pressure. World J Gastroenterol (2015) 0.75
New devices and techniques for endoscopic closure of gastrointestinal perforations. World J Gastroenterol (2016) 0.75
Outcomes of transjugular intrahepatic portosystemic shunts for ascites. Semin Intervent Radiol (2014) 0.75
Self-expanding metal stents for acute refractory esophageal variceal bleeding: A systematic review and meta-analysis. Dig Endosc (2016) 0.75
Transjugular intrahepatic portosystemic shunt (TIPS) versus laparoscopic splenectomy (LS) plus preoperative endoscopic varices ligation (EVL) in the treatment of recurrent variceal bleeding. Surg Endosc (2013) 0.75
Acute variceal hemorrhage in patients with liver cirrhosis: weekend versus weekday admissions. Yonsei Med J (2012) 0.75
[Complications of end-stage liver disease]. Can Fam Physician (2016) 0.75
Sengstaken-Blakemore tube for non-variceal distal esophageal bleeding refractory to endoscopic treatment: a case report & review of the literature. Gastroenterol Rep (Oxf) (2014) 0.75
A Prospective Randomized Study on the Risk of Bacteremia in Banding versus Sclerotherapy of Esophageal Varices. Front Med (Lausanne) (2016) 0.75
Early TIPS in U.S. Patients Hospitalized with Acute Esophageal Variceal Bleeding. J Gastroenterol Hepatol (2016) 0.75
Spleen Stiffness Is Superior to Liver Stiffness for Predicting Esophageal Varices in Chronic Liver Disease: A Meta-Analysis. PLoS One (2016) 0.75
Gastrointestinal hemorrhage: should we transfuse less? Dig Dis Sci (2008) 0.75
Diagnosis and Management of Hepatobiliary Complications in Autosomal Recessive Polycystic Kidney Disease. Front Pediatr (2017) 0.75
Rendering factor Xa zymogen-like as a therapeutic strategy to treat bleeding. Curr Opin Hematol (2017) 0.75
Role of endoscopic ultrasound in liver disease: Where do we stand in 2017? World J Hepatol (2017) 0.75
Predictors of esophageal varices and first variceal bleeding in liver cirrhosis patients. World J Gastroenterol (2017) 0.75
Variceal bleeding and long-acting octreotide: a new addition to the armamentarium? Dig Dis Sci (2008) 0.75
Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (2005) 29.57
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology (2007) 9.44
Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med (2005) 6.31
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology (2012) 5.47
Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology (2003) 4.69
Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome. Am J Med (2008) 4.07
Management of Crohn's disease in adults. Am J Gastroenterol (2009) 3.94
Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology (2008) 3.68
A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology (2007) 3.65
The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol (2013) 3.51
The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology (2009) 3.48
Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology (2004) 3.45
Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA (2011) 3.37
Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. Gastroenterology (2007) 3.06
Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology (2011) 2.97
The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome. Hepatology (2007) 2.94
Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology (2010) 2.86
Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis. Gastroenterology (2013) 2.82
Sepsis-induced cholestasis. Hepatology (2007) 2.80
Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. Gastroenterology (2013) 2.70
Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol (2009) 2.42
Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology (2009) 2.40
The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol (2011) 2.37
Role of esophageal stents in benign and malignant diseases. Am J Gastroenterol (2009) 2.32
An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clin Gastroenterol Hepatol (2010) 2.18
Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design. Contemp Clin Trials (2008) 2.17
Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics. J Hepatol (2010) 2.16
Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy. Hepatology (2009) 2.16
Hepatitis C virus infection: molecular pathways to metabolic syndrome. Hepatology (2008) 2.10
Association of AKI with mortality and complications in hospitalized patients with cirrhosis. Hepatology (2012) 2.01
Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr (2007) 1.99
Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab (2012) 1.97
Clostridium difficile is associated with poor outcomes in patients with cirrhosis: A national and tertiary center perspective. Am J Gastroenterol (2009) 1.93
The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy. Hepatology (2013) 1.92
Treatment of chronic hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alpha. Hepatology (2007) 1.90
Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury. Hepatology (2014) 1.89
Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysis. Hepatology (2012) 1.86
MELD-XI: a rational approach to "sickest first" liver transplantation in cirrhotic patients requiring anticoagulant therapy. Liver Transpl (2007) 1.86
Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol (2011) 1.85
Cirrhotic cardiomyopathy. J Am Coll Cardiol (2010) 1.77
Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation. Liver Transpl (2004) 1.76
Effect of hyponatraemia on outcomes following orthotopic liver transplantation. Liver Int (2009) 1.76
Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). J Hepatol (2012) 1.70
Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression. Clin Gastroenterol Hepatol (2011) 1.65
Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis. Hepatology (2011) 1.63
The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol (2012) 1.61
Portal hypertensive bleeding. Gastroenterol Clin North Am (2003) 1.60
Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child-Pugh and MELD scores. Clin Gastroenterol Hepatol (2004) 1.60
Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data. Liver Int (2009) 1.59
Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology (2010) 1.58
Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology (2010) 1.55
Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C. Gastroenterology (2010) 1.52
Recent advances in nonalcoholic fatty liver disease. Curr Opin Gastroenterol (2010) 1.52
Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PLoS One (2013) 1.51
Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology (2006) 1.50
Treatment of nonalcoholic fatty liver disease in children: TONIC trial design. Contemp Clin Trials (2009) 1.48
Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1. Liver Transpl (2011) 1.44
Recurrent variceal bleeding despite endoscopic and medical therapy. Gastroenterology (2004) 1.39
Ascites: diagnosis and management. Med Clin North Am (2009) 1.37
Drug-induced steatohepatitis. Clin Liver Dis (2003) 1.36
A comparison of the spectrum of chronic hepatitis C virus between Caucasians and African Americans. Clin Gastroenterol Hepatol (2004) 1.33
Endoplasmic reticulum stress and the unfolded protein response. Clin Liver Dis (2009) 1.28
Prevention of free fatty acid-induced hepatic lipotoxicity by 18beta-glycyrrhetinic acid through lysosomal and mitochondrial pathways. Hepatology (2008) 1.24
Obesity and non-alcoholic fatty liver disease in chronic hepatitis C. J Clin Gastroenterol (2004) 1.23
Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Clin Liver Dis (2004) 1.22
Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis. Hepatology (2008) 1.21
Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites. Am J Gastroenterol (2009) 1.21
Portal hypertension and variceal hemorrhage. Med Clin North Am (2008) 1.19
Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease. Am J Gastroenterol (2010) 1.17
The clinicopathologic spectrum and management of nonalcoholic fatty liver disease. Adv Anat Pathol (2002) 1.16
The metabolic abnormalities associated with non-alcoholic fatty liver disease. Best Pract Res Clin Gastroenterol (2002) 1.16
Hepatitis C and nonalcoholic fatty liver disease. Semin Liver Dis (2004) 1.15
HIV protease inhibitors induce endoplasmic reticulum stress and disrupt barrier integrity in intestinal epithelial cells. Gastroenterology (2009) 1.15
Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. Clin Gastroenterol Hepatol (2009) 1.14
Recent advances in nonalcoholic fatty liver disease. Curr Opin Gastroenterol (2009) 1.13
A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis. Hepatology (2011) 1.12
Clinical aspects of fatty liver disease. Semin Liver Dis (2004) 1.11
Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients. Hepatology (2013) 1.10
Recent advances in nonalcholic fatty liver disease. Curr Opin Gastroenterol (2008) 1.10
Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C. Am J Gastroenterol (2005) 1.09
Treatment of chronic hepatitis C virus in the virginia department of corrections: can compliance overcome racial differences to response? Am J Gastroenterol (2004) 1.08
Evaluation and management of non-alcoholic steatohepatitis. J Hepatol (2004) 1.07
The effect of fatigue on driving skills in patients with hepatic encephalopathy. Am J Gastroenterol (2009) 1.06
Abnormalities of lipid metabolism in nonalcoholic fatty liver disease. Semin Liver Dis (2008) 1.05
A decision analysis study of the value of a liver biopsy in nonalcoholic steatohepatitis. Liver Int (2008) 1.01
Association between puberty and features of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol (2012) 1.01
Noninvasive tests for liver disease, fibrosis, and cirrhosis: Is liver biopsy obsolete? Cleve Clin J Med (2010) 1.00
Comparison of three commercially available assays for HCV RNA using the international unit standard: implications for management of patients with chronic hepatitis C virus infection in clinical practice. Am J Gastroenterol (2003) 1.00
A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation. Liver Transpl (2007) 0.99
Novel treatment modalities for nonalcoholic steatohepatitis. Trends Endocrinol Metab (2010) 0.96
Vitamin E and nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care (2012) 0.96
Hepatitis B virus infection: understanding its epidemiology, course, and diagnosis. Cleve Clin J Med (2008) 0.96
Metabolomic profiling to identify predictors of response to vitamin E for non-alcoholic steatohepatitis (NASH). PLoS One (2012) 0.96
Scavenger receptor A restrains T-cell activation and protects against concanavalin A-induced hepatic injury. Hepatology (2013) 0.94
Lipotoxicity in NASH. J Hepatol (2011) 0.94
The histologic spectrum of nonalcoholic fatty liver disease. Clin Liver Dis (2004) 0.94
Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trial. Am J Gastroenterol (2006) 0.93
Diagnosis of celiac disease in adults based on serology test results, without small-bowel biopsy. Clin Gastroenterol Hepatol (2013) 0.93